Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Polycystic Ovary Syndrome × Levonorgestrel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1 Ovarian Neoplasms 1 Multiple Endocrine Neoplasia Type 1 1 Leukemia, Lymphocytic, Chronic, B-Cell 1 Endometrial Neoplasms 1 Endometrial Hyperplasia 1

Interventions

Metformin 131 Clomiphene 45 Letrozole 35 Inositol 31 Folic Acid 16 Progesterone 14 Exercise 14 Chorionic Gonadotropin 13 drospirenone and ethinyl estradiol combination 12 Ethinyl Estradiol 12 Caloric Restriction 12 Estradiol 11 cetrorelix 10 Contraceptives, Oral 10 Spironolactone 9 Pioglitazone 9 Cholecalciferol 9 Triptorelin Pamoate 8 Tablets 8 High-Intensity Interval Training 8 Diet 8 Menotropins 7 Acupuncture Therapy 7 drospirenone 6 Thioctic Acid 6 Ovidrel 6 Liraglutide 6 Gonadotropins 6 Flutamide 6 Exenatide 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03043924 2025-12-11

MRI-PCOS

University Hospital, Lille

Phase NA Completed

Polycystic Ovary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡